Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Incontinence
Law Firm Confirms Health Risks for Women Raised by New FDA Med Alert
November 16th, 2008
On October 20, the FDA issued a Med Alert to physicians and healthcare providers that cites serious complications from vaginal slings. This is a class of product marketed to treat stress urinary incontinence, a condition estimated to affect as many as 14 million women across the nation. Vaginal slings are constructed with surgical mesh designed to reinforce weakened bladder and urethra muscles that involuntarily release urine during moments of physical stress. The law firm of Blasingame, Burch, Garrard & Ashley of Athens, Georgia, is handling the largest number of lawsuits in the country related to vaginal sling injuries. At present, they represent plaintiffs, with...
Source: Pharma Investments, Ventures & Law Weekly (2008-11-16)
|
